Synokem Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
- Paid Up Capital ₹ 45.00 Cr
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 115.00 Cr
- Satisfied Charges ₹ 19.00 Cr
- Revenue Growth 1626.01%
- Profit Growth -46151.36%
- Ebitda -4845.96%
- Net Worth -31.36%
- Total Assets 180.73%
About Synokem Lifesciences
Synokem Lifesciences Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2020 (Four years and ten months 25 days old ). Its registered office is in West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 45.00 Cr.
The company currently has active open charges totaling ₹115.00 Cr. The company has closed loans amounting to ₹19.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Synokem Lifesciences Private Limited India are Vinay Purwar as COMPANY SECRETARY and Danbeer Singh as Cfo. Abhinav Arora, Thomas Baby, and Vishal Gupta serve as directors at the Company.
Company Details
-
Location
West Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230DL2020PTC362777
-
Company No.
362777
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Mar 2020
-
Date of AGM
24 Nov 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Synokem Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Arora
|
Managing Director | 14-Mar-2020 | Current |
| Vinay Purwar | Company Secretary | 30-Jan-2021 | Current |
| Danbeer Singh | CFO | 30-Jan-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Thomas Baby
|
Director | 03-May-2022 | Current |
|
Vishal Gupta
|
Nominee Director | 18-Jan-2023 | Current |
Financial Performance of Synokem Lifesciences.
Synokem Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1626.01% increase. The company also saw a substantial fall in profitability, with a 46151.36% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synokem Lifesciences?
In 2023, Synokem Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Omniactive Health Technologies LimitedVishal Gupta is a mutual person
-
Synokem Pharmaceuticals LimitedAbhinav Arora, Thomas Baby and 2 more are mutual person
-
Nitin Lifesciences LimitedAbhinav Arora and Vishal Gupta are mutual person
-
Spl Packaging Limited Liability Partners HipAbhinav Arora is a mutual person
-
Kemsyn Lifesciences Private Limited
Abhinav Arora and Thomas Baby are mutual person
-
James & Abhi Ventures Private Limited
Abhinav Arora is a mutual person
Charges (Loans)
₹115.00 Cr
₹19.00 Cr
Charges Breakdown by Lending Institutions
- Others : 115.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2023 | Others | ₹115.00 Cr | Open |
| 28 Apr 2022 | Others | ₹19.00 Cr | Satisfied |
How Many Employees Work at Synokem Lifesciences?
Synokem Lifesciences has a workforce of 222 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synokem Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synokem Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
